Eisai clinches Merck deal to develop and sell cancer drug, shares soar

(This March 8 story has been corrected to show in the 7th paragraph that Merck will pay, not receive, R&D reimbursement)

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *